Raphaela Goldbach-Mansky Selected Research

Interferon Type I

1/2022	Pathogenic insights from genetic causes of autoinflammatory inflammasomopathies and interferonopathies.
2/2017	Familial chilblain lupus due to a gain-of-function mutation in STING.
9/2015	Newly recognized Mendelian disorders with rheumatic manifestations.
7/2015	New monogenic autoinflammatory diseases--a clinical overview.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raphaela Goldbach-Mansky Research Topics

Disease

36	Cryopyrin-Associated Periodic Syndromes 07/2023 - 12/2002
27	Inflammation (Inflammations) 04/2024 - 08/2006
12	Bites and Stings (Sting) 01/2022 - 09/2015
11	Fever (Fevers) 05/2021 - 08/2007
9	Rheumatoid Arthritis 04/2024 - 01/2003
7	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2022 - 12/2011
7	Infections 11/2022 - 08/2007
7	Macrophage Activation Syndrome 07/2020 - 10/2014
6	Mevalonate Kinase Deficiency 01/2022 - 06/2013
6	Exanthema (Rash) 07/2017 - 08/2006
5	Skin Diseases (Skin Disease) 01/2023 - 11/2013
5	Osteomyelitis 01/2021 - 12/2011
5	Gout 01/2014 - 01/2008
4	chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature 04/2024 - 03/2012
4	Lipodystrophy 01/2023 - 11/2015
4	COVID-19 11/2022 - 10/2020
4	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2022 - 12/2008
4	Lung Diseases (Lung Disease) 01/2022 - 09/2010
4	Familial Mediterranean Fever (Periodic Disease) 01/2021 - 06/2013
4	Dermatomyositis (Dermatopolymyositis) 01/2020 - 11/2019
3	Amyloidosis 02/2024 - 12/2022
3	Autoimmune Diseases (Autoimmune Disease) 10/2022 - 01/2018
3	Necrosis 01/2022 - 01/2021
3	Majeed syndrome 01/2021 - 12/2011
3	autosomal dominant familial Periodic fever 01/2021 - 07/2008
3	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2020 - 07/2015
3	Aseptic Meningitis 06/2017 - 08/2007
3	Arthritis (Polyarthritis) 01/2014 - 01/2003
2	Ulcer 01/2023 - 01/2017
2	Neutropenia 01/2022 - 01/2021
2	Pyogenic arthritis, pyoderma gangrenosum, and acne 01/2021 - 06/2013
2	Pharyngitis (Sore Throat) 01/2021 - 04/2011
2	Lymphadenitis (Adenitis) 01/2021 - 04/2011
2	Pneumonia (Pneumonitis) 01/2021 - 10/2020
2	Aphthous Stomatitis (Aphthous Ulcer) 01/2021 - 04/2011
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2020 - 07/2015
2	Enterocolitis 01/2018 - 09/2010
2	Chronic Disease (Chronic Diseases) 01/2018 - 11/2015
2	Hearing Loss (Hearing Impairment) 12/2017 - 08/2011
2	Body Weight (Weight, Body) 12/2017 - 08/2006
2	Anaphylaxis (Anaphylactic Shock) 07/2017 - 05/2009
2	Urticaria (Hives) 06/2017 - 05/2009
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2014 - 09/2010
2	Neoplasms (Cancer) 01/2011 - 09/2009
2	Joint Diseases (Joint Disease) 08/2007 - 01/2003
2	Spondylarthropathies 04/2003 - 01/2003
1	Nephrotic Syndrome (Syndrome, Nephrotic) 07/2023
1	Amyloid Plaque 07/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Abdominal Pain (Pain, Abdominal) 01/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023

Drug/Important Bio-Agent (IBA)

26	Interleukin-1 (Interleukin 1)IBA 01/2022 - 12/2002
19	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 02/2024 - 08/2006
12	Proteins (Proteins, Gene)FDA Link 07/2023 - 07/2006
12	InflammasomesIBA 01/2022 - 12/2009
11	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 07/2023 - 12/2002
10	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2024 - 03/2012
10	InterferonsIBA 11/2022 - 01/2018
9	AutoantibodiesIBA 10/2020 - 01/2003
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2008
7	CytokinesIBA 11/2022 - 12/2002
7	Interleukin-18 (Interleukin 18)IBA 01/2020 - 07/2015
6	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 12/2002
5	baricitinibIBA 04/2024 - 04/2015
5	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2021 - 07/2008
5	InterleukinsIBA 11/2013 - 07/2008
4	Interferon Type IIBA 01/2022 - 07/2015
3	Deficiency of interleukin-1 receptor antagonistIBA 01/2021 - 06/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 07/2008
3	PyrinIBA 01/2020 - 12/2002
3	C-Reactive ProteinIBA 06/2017 - 08/2008
3	canakinumab FDA Link 01/2017 - 12/2011
3	AntibodiesIBA 09/2009 - 01/2003
2	Janus Kinase InhibitorsIBA 04/2024 - 01/2016
2	src-Family KinasesIBA 01/2023 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2023 - 10/2022
2	Antiviral Agents (Antivirals)IBA 11/2022 - 01/2018
2	UbiquitinIBA 01/2022 - 01/2021
2	EnzymesIBA 05/2021 - 04/2003
2	LigandsIBA 01/2021 - 02/2017
2	Immunoglobulin E (IgE)IBA 01/2021 - 05/2009
2	Immunoglobulin G (IgG)IBA 10/2020 - 01/2003
2	Interleukin-6 (Interleukin 6)IBA 07/2020 - 01/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 12/2011
2	Adenosine DeaminaseIBA 01/2020 - 03/2014
2	Etanercept (Enbrel)FDA Link 12/2017 - 05/2009
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 06/2017 - 08/2008
2	Uric Acid (Urate)IBA 01/2014 - 01/2008
2	NF-kappa B (NF-kB)IBA 05/2012 - 05/2012
2	rilonacept FDA Link 12/2011 - 08/2008
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 08/2009 - 05/2009
2	Interleukin-1beta (Interleukin 1 beta)IBA 08/2008 - 08/2006
1	Congo RedIBA 07/2023
1	Dasatinib (BMS 354825)FDA Link 01/2023

Therapy/Procedure

11	Therapeutics 11/2022 - 07/2008
3	Injections 07/2023 - 08/2006
2	Aftercare (After-Treatment) 01/2017 - 01/2012
2	Biological Therapy 01/2016 - 05/2009
1	Drug Tapering 04/2024
1	Subcutaneous Injections 07/2023